Standout Papers

Guideline of transthyretin-related hereditary amyloidosis for clinicians 2012 2026 2016 2021 473
  1. Guideline of transthyretin-related hereditary amyloidosis for clinicians (2013)
    Yukio Ando, Teresa Coelho et al. Orphanet Journal of Rare Diseases
  2. Transthyretin (TTR) Cardiac Amyloidosis (2012)
    Frederick L. Ruberg, John L. Berk Circulation
  3. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis (2019)
    Scott D. Solomon, David Adams et al. Circulation
  4. Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial (2022)
    David Adams, Ivailo Tournev et al. Amyloid

Immediate Impact

7 by Nobel laureates 14 from Science/Nature 79 standout
Sub-graph 1 of 15

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis
2024 StandoutNature
6 intermediate papers

Works of John L. Berk being referenced

Retinoic acid-induced inhibition of type I collagen gene expression by human lung fibroblasts
1994
Recombinant interleukin-1 beta inhibits elastin formation by a neonatal rat lung fibroblast subtype.
1991
and 6 more

Author Peers

Author Last Decade Papers Cites
John L. Berk 5823 1615 1099 1395 154 6.5k
Laura Obici 7767 1750 1148 1628 175 8.6k
Ole B. Suhr 7099 1571 960 1527 228 8.7k
Stefan Schönland 5691 1337 731 1478 222 6.9k
Carol Whelan 4615 2113 822 1183 125 5.5k
Vaishali Sanchorawala 7396 1982 1146 1648 274 8.0k
Raymond L. Comenzo 6545 1293 881 2376 227 8.1k
Martha Grogan 5663 2446 1181 1698 180 7.7k
Steven R. Zeldenrust 7460 1208 717 3668 165 9.7k
Ashutosh Wechalekar 8906 3046 1382 2151 262 10.0k
Frederick L. Ruberg 4498 1945 899 1213 119 6.9k

All Works

Loading papers...

Rankless by CCL
2026